Immutep Health Care
Cancer Pharmaceuticals

$0.315 0.010 (3.28%)

High $0.32	Low $0.30	Trades 243	Turnover $627,825	Volume 2,012,212
30 June 2023 at 4:10pm

Market Cap (5-Aug) $70,738,624 (530th)	Close (30-Jun) $0.315 0.01 (3.28%)	Volume (30-Jun) 2,012,212	Shortsold (29-Jul) 44,537,538 (3.02%) (106th)
52w High $0.470	52w Low $0.028	P/E 7.20	EPS -0.04

[ARTICLE] ASX to edge higher; Newmont increases bid for Newcrest

MediaBot

April 11, 2023 09:44

A news article has been posted about Immutep on the AFR. The article was published around April 11, 2023 09:44, on 11 April 2023 at 9:44am.

Lucy Turnbull has stepped down from her role as non-executive director at Immutep and will be replaced by Lis Boyce. Ms Turnbull re-joined the company’s board after the sudden death of Grant Chamberlain in January 2022. Ms Boyce is a highly experienced ...

Read Article

IMM was $0.24 at the close of trade on 06 April 2023

Recent Articles about ASX:IMM
20-Dec	Immutep MS therapy IMP761 found safe in initial Phase 1 trial data multiplesclerosisnewstoday.com
18-Dec	Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 uk.finance.yahoo.com
17-Dec	Immutep Announces Initial Safety Data From First-In-Human Phase I Trial Evaluating IMP761 menafn.com
17-Dec	Immutep, Monash Reveal LAG-3 Binding to MHC Class II miragenews.com
17-Dec	Health Check: Clinical trials don’t sleigh down for the silly season msn.com
17-Dec	Immutep dips as safety test for flagship drug IMP761 shows no adverse effects msn.com
17-Dec	Immutep Reveals Promising Data for IMP761 Trial markets.businessinsider.com
17-Dec	Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to MHC Class II markets.businessinsider.com
16-Dec	Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to MHC Class II manilatimes.net
16-Dec	Study Sheds Light on New Ways for Immunotherapy to Better Target Cancer technologynetworks.com
Tracked

Find all articles about Immutep, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

End of Day Prices

Date	Close	Volume	Change
04-Aug	$0.05	3,550,287	+0.00 (2.17%)
03-Aug	$0.05	2,940,611	0.00 (0.00%)
31-Jul	$0.05	2,758,273	0.00 (0.00%)
30-Jul	$0.05	7,305,934	0.00 (2.13%)
29-Jul	$0.05	2,167,778	0.00 (0.00%)
28-Jul	$0.05	25,866,235	0.00 (2.08%)
27-Jul	$0.05	4,965,061	0.00 (0.00%)
24-Jul	$0.05	14,492,733	0.00 (4.00%)
23-Jul	$0.05	3,003,770	0.00 (0.00%)
22-Jul	$0.05	16,763,215	+0.00 (2.04%)
21-Jul	$0.05	3,550,883	0.00 (2.00%)
20-Jul	$0.05	12,370,257	0.00 (0.00%)
17-Jul	$0.05	24,511,699	-0.20 (80.00%)
18-Sep	$0.25	826,810	+0.02 (8.70%)
12-Sep	$0.23	1,043,977	-0.01 (4.17%)
3 up, 6 down, and 6 flat days

Immutep Health Care
Cancer Pharmaceuticals

[ARTICLE] ASX to edge higher; Newmont increases bid for Newcrest

MediaBot

Followers

Prices

Announcements

End of Day Prices

IMM Immutep Health Care Cancer Pharmaceuticals

[ARTICLE] ASX to edge higher; Newmont increases bid for Newcrest

MediaBot

Followers

Prices

Announcements

End of Day Prices

Immutep Health Care
Cancer Pharmaceuticals